Stockreport

Roivant stock rises after Vtama meets main goal of 2nd phase 3 eczema study [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF Roivant stock rises after Vtama meets main goal of 2nd phase 3 eczema studyMay 16, 2023 7:39 AM ETRoivant Sciences Ltd. (ROIV)By:RavikashSA EditorAsiaVisionDermavant Sc [Read more]